ArticleFrontiers in immunology2026

TACE-HAIC combined with apatinib and camrelizumab for unresectable hepatocellular carcinoma with portal vein tumor thrombus: a multicenter retrospective study.

Xuexian Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.